Federal Employees Not Eligible for Social Security Benefits: United States Court of Appeals

Published Date: 16 Feb 2023

A divided U.S. appeals court ruled on Tuesday that federal workers generally do not deserve extra pay for being exposed to the COVID-19 virus on the job.

Read Full News

Latest News

Fungal Extract May Improve COVID Vaccine Response

Researchers report that fungal extracts may influence vaccine reactogenicity and antibody kinetics, with effects observed only in individuals without prior SARS-CoV-2 exposure.

Can Severe Infections Raise Your Dementia Risk?

Severe infections such as cystitis and bacterial infection of an unspecified site may raise the risk of developing dementia, even after accounting for other illnesses.

Exclusive-US Upends Global Supply Program for Malaria and HIV Amid Warnings of Gaps

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

African Ancestry Linked to Fewer TB Adverse Events

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical Cancer Screening Update: Why Less Is More

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Exclusive-Pfizer, BioNTech Halt US COVID Vaccine Study After Recruitment Struggles

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

Researchers report that fungal extracts may influence vaccine reactogenicity and antibody kinetics, with effects observed only in individuals without prior SARS-CoV-2 exposure.

Severe infections such as cystitis and bacterial infection of an unspecified site may raise the risk of developing dementia, even after accounting for other illnesses.

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

News All Time

UK Says Vaccine Protects Against Strain in Deadly Meningitis Outbreak

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

Sudan Clinics Could Run Out of Supplies Due to Middle East War

Medical supplies to clinics dealing with the humanitarian crisis in Sudan could run out within 2 weeks unless ⁠shipments are rapidly rerouted.

Around 4.9 Million Children Under Five Died in 2024, Says UN

About 4.9 million children died before reaching their fifth birthday in 2024, according to new United Nations estimates, a sign progress ⁠to reduce child mortality rates was...

UK Races to Contain Meningitis Outbreak in Kent After Two Deaths

Britain will roll out meningitis vaccines to students at a university in southeast England after an "unprecedented" outbreak of the disease killed two people while the...

Treating Gonorrhea Orally: Access vs Resistance

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

Starting HIV PrEP in the Second Trimester Appears Safe

In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.

Drop in HIV/HCV Coinfections After Nationwide HCV Program

Following Iceland’s national hepatitis C elimination program, a substantial reduction was observed in the number of HIV/hepatitis C virus coinfections from 2016 to 2020.

Doctors Warn of a Deadly Complication From Measles Outbreaks

Measles causes complications — ranging from diarrhea to death — in 3 in 10 infected people, according to the Infectious Diseases Society of America.

Physician Groups Applaud Decision to Pause Vaccine Overhaul

A federal judge found that HHS acted illegally in appointing vaccine advisers and unilaterally changing the immunization schedule.

FDA Approves Expanded Age Indication for RSV Vaccine

The FDA has approved expanded use of Arexvy, an RSV vaccine, for those aged 18-49 at increased LRTD risk.

Same-Day ART Matches Delayed ART for HIV With TB Symptoms

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until tuberculosis test results are available, with similar viral suppression.

US Insurers and Hospitals Turn to New AI for Age-old Battle Over Charges Vs Payments

Artificial intelligence is being deployed on both sides of the tug-of-war between U.S. healthcare systems that want to be paid more for medical procedures and insurers who...

Viatris Settles lawsuit Over Use Of Woman's 'immortal' Cells to Power Drug Research

Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose ⁠tissue samples were used without her permission to develop...

RSV Hospitalization Burden Rises With Age and Comorbidities

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

US Vaccine Advisers Drop Plan to Question MRNA COVID Shots, WaPo Reports

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

South Carolina Reports One Additional Measles Case, Total Cases Rise to 991

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

Recommended News For You

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

Nuclear missile workers are contracting cancer: They blame the bases

Researchers find distinct cell receptors with the potential for new treatments.

When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

Recommended Articles For You

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51% 

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction 

Tazemetostat: A Promising New Treatment for Cancer 

Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

2.

FDA Approves Hemophilia B Second Gene Therapy.

3.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

4.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

5.

Study finds that AI is better at forecasting the risk of developing cancer.

1.

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options 

2.

Navigating the Complexities of Esophageal Cancer Staging

3.

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds

4.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

5.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

3.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

4.

A New Era in Managing Cancer-Associated Thrombosis

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot